Literature DB >> 20952174

Prevalence of COPD in Copenhagen.

Peder Fabricius1, Anders Løkke, Jacob Louis Marott, Jørgen Vestbo, Peter Lange.   

Abstract

INTRODUCTION: COPD is a leading cause of death worldwide; however, prevalence estimates have varied considerably in previous studies. This study aimed to determine the prevalence and severity of COPD in Copenhagen using data from the 4th examination of The Copenhagen City Heart Study, to investigate the relationship between tobacco consumption and COPD, and to characterize the subjects with COPD with regard to BMI, dyspnoea, treatment with respiratory medication and co-morbidities.
METHODS: 6236 people participated. All non-asthmatic participants aged 35 years or older with adequate lung function data were included for the final prevalence analyses (n = 5,299). COPD staging was done according to the GOLD criteria.
RESULTS: The overall prevalence of COPD was 17.4%. The prevalence increased with age and was higher among males. 6.2% had mild COPD, 9.2% had moderate COPD, and 2.0% had severe or very severe COPD. Tobacco consumption was closely linked to both prevalence and disease severity. Subjects with COPD had lower mean Body Mass Index (BMI) and more frequently a BMI < 21 kg/m(2). Dyspnoea was correlated to lung function but a substantial number of participants with severe COPD experienced no dyspnoea. Only a minority of subjects with COPD received pulmonary medication. COPD was associated with cardiovascular disease and cancer.
CONCLUSION: The prevalence of COPD in Denmark is among the highest in the world. It is closely correlated to smoking and age. It is accompanied by substantial co-morbidity and it is grossly under treated.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20952174     DOI: 10.1016/j.rmed.2010.09.019

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  23 in total

1.  Ethnic Differences in Persistence with COPD Medications: a Register-Based Study.

Authors:  Yusun Hu; Lourdes Cantarero-Arévalo; Anne Frølich; Ramune Jacobsen
Journal:  J Racial Ethn Health Disparities       Date:  2017-04-13

2.  Ethnic Inequalities in COPD Outcomes: a Register-Based Study in Copenhagen, Denmark.

Authors:  Yusun Hu; Lourdes Cantarero-Arévalo; Anne Frølich; Ramune Jacobsen
Journal:  J Racial Ethn Health Disparities       Date:  2016-12-15

Review 3.  The diagnosis of chronic obstructive pulmonary disease.

Authors:  Rainer Burkhardt; Wulf Pankow
Journal:  Dtsch Arztebl Int       Date:  2014-12-05       Impact factor: 5.594

Review 4.  Effectiveness of pulmonary rehabilitation in COPD with mild symptoms: a systematic review with meta-analyses.

Authors:  Mette Rugbjerg; Ulrik Winning Iepsen; Karsten Juhl Jørgensen; Peter Lange
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-04-17

5.  Effects of Vitamin D Intake on FEV1 and COPD Exacerbation: A Randomized Clinical Trial Study.

Authors:  Abolfazl Zendedel; Mohammadreza Gholami; Khatereh Anbari; Kourosh Ghanadi; Elham Ceneicel Bachari; Alireza Azargon
Journal:  Glob J Health Sci       Date:  2015-01-14

6.  Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung disease.

Authors:  Anders Løkke; Lars Ahlbeck; Leif Bjermer; Jann Mortensen; Anders Østrem; Iris Pasternack; Guilherme Safioti; Saku Torvinen
Journal:  Eur Clin Respir J       Date:  2015-12-16

7.  Epidemiology of chronic obstructive pulmonary disease: a population-based study in Krasnoyarsk region, Russia.

Authors:  Ivan P Artyukhov; Irina L Arshukova; Elena A Dobretsova; Tatyana A Dugina; Andrey V Shulmin; Irina V Demko
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-02

Review 8.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

Review 9.  Effects of chronic obstructive pulmonary disease and obstructive sleep apnea on cognitive functions: evidence for a common nature.

Authors:  Georgia Andreou; Filippos Vlachos; Konstantinos Makanikas
Journal:  Sleep Disord       Date:  2014-02-06

10.  The PROTECCT-M study: a cohort study investigating associations between novel specific biomarkers, patient-related, healthcare system markers and the trajectory of COPD patients treated in primary care.

Authors:  Jens Søndergaard; Anders Halling
Journal:  BMC Pulm Med       Date:  2014-05-20       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.